Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: AbbVie
Woman and Man Max 99 years
AbbVie
Update Il y a 4 ans
Adalimumab in low back pain
Background and study aims Lower back pain is a common problem, which affects most people at some point in their lives. Many people who experience LBP will recover quickly with no significant impact to...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
AbbVie Deutschland GmbH & Co. KG
Update Il y a 4 ans
A Study to Compare Study Drug ABT-494 to Placebo in Adult Subjects with Moderate to Severe Atopic Dermatitis (Atopic Eczema)
To evaluate the safety and efficacy of multiple doses of ABT-494 monotherapy versus placebo in the treatment of adults with moderate to severe atopic dermatitis
Country
None
organs
None
Specialty
None
unknown
More information
Woman Max 99 years
AbbVie Deutschland GmbH & Co. KG
Update Il y a 4 ans
Veliparib in combination with carboplatin and paclitaxel and as continuation maintenance therapy in subjects with newly diagnosed, untreated Stage III or IV high-grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer
The primary objective of the study is to evaluate whether progression-free survival (PFS) is prolonged when veliparib is added to standard platinum-based chemotherapy and then continued as maintenance...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
AbbVie Deutschland GmbH & Co. KG
Update Il y a 4 ans
A Phase 2a Study Evaluating the Safety, Efficacy, and Pharmacodynamic Effects of ABT-981 in Patients with Knee Osteoarthritis
To assess the effect of ABT-981 on OA knee pain using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) at Week 16 and synovitis/effusion volume of the index knee using quanti...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
AbbVie Deutschland GmbH & Co. KG
Update Il y a 4 ans
A Phase 3, Multicenter, Double-Blind, Randomized, Parallel-Arm, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Adalimumab for Treatment of Nail Psoriasis in Subjects with Chronic Plaque Psoriasis
The primary objective of this study is to evaluate the safety and efficacy of adalimumab for treatment of nail psoriasis.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
AbbVie Stemcentrx LLC
Update Il y a 4 ans
A Clinical Trial to observe the effects of the test drug Rovalpituzumab Tesirine in patients with a particular form of Lung Cancer where no lasting efficacy has been achieved on at least two previous therapies
To investigate the efficacy of rovalpituzumab tesirine as third-line and later treatment for subjects with relapsed or refractory delta-like protein 3 (DLL3)-expressing small cell lung cancer (SCLC)
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
AbbVie Deutschland GmbH & Co. KG
Update Il y a 4 ans
A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects with Early Alzheimer's Disease Se trata de un estudio para evaluar la eficacia y la seguridad de ABBV 8E12 en pacientes con enfermedad de Alzheimer incipiente
• To assess the efficacy of ABBV-8E12 in slowing disease progression (cognitive and functional impairment) in subjects with Early Alzheimer's Disease (AD) as measured by the Clinical Dementia Rating –...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man
Between 18 years
and 99 years
AbbVie
Update Il y a 6 ans
Étude Intellance 1 (M13-813) : étude de phase 2-3 randomisé en double aveugle, comparant l’efficacité et la tolérance d’un traitement associant radio-chimiothérapie, temozolomide et ABT-414, par rapport à un traitement associant radio-chimiothérapie, temozolomide et placebo, chez des patients ayant un glioblastome nouvellement diagnostiqué et porteur d’un amplification d’EGFR. [Informations issues du site clinicaltrials.gov et traduites par l'INCa]
Intellance 1 (M13-813) - A randomized, placebo controlled phase 2b/3 Study of ABT-414 with concurrent chemoradiation and adjuvant temozolomide in subjects with newly diagnosed glioblastoma (GBM) with ...
Country
France
organs
Cerveau
Specialty
Radiothérapie et Chimiothérapie
,
Thérapies Ciblées
Essai ouvert aux inclusions
More information
Woman and Man Max 99 years
AbbVie Deutschland GmbH & Co. KG
Update Il y a 4 ans
A Multicenter, Open-Label Study to Evaluate the Long Term Efficacy, Safety, and Tolerability of Repeated Administration of Adalimumab in Subjects with Crohn's Disease
The primary objective of this study is to evaluate the long-term efficacy, safety, and tolerability of repeated administration of adalimumab in subjects with Crohn's disease (CD).
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
AbbVie Deutschland GmbH & Co. KG
Update Il y a 4 ans
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Major Surgery
- To determine the safety and pharmacokinetics of 800 mcg/kg intravenous (IV) infusions of ABT-719 in the first 6 subjects enrolled who are at risk of acute kidney injury (AKI) and undergoing high r...
Country
None
organs
None
Specialty
None
Closed trial
More information
Previous
5
6
7
8
9
10
11
12
13
14
Next